Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Mar;65(3):477-489.
doi: 10.1007/s00125-021-05635-9. Epub 2021 Dec 24.

Multi-ethnic GWAS and fine-mapping of glycaemic traits identify novel loci in the PAGE Study

Affiliations
Meta-Analysis

Multi-ethnic GWAS and fine-mapping of glycaemic traits identify novel loci in the PAGE Study

Carolina G Downie et al. Diabetologia. 2022 Mar.

Abstract

Aims/hypothesis: Type 2 diabetes is a growing global public health challenge. Investigating quantitative traits, including fasting glucose, fasting insulin and HbA1c, that serve as early markers of type 2 diabetes progression may lead to a deeper understanding of the genetic aetiology of type 2 diabetes development. Previous genome-wide association studies (GWAS) have identified over 500 loci associated with type 2 diabetes, glycaemic traits and insulin-related traits. However, most of these findings were based only on populations of European ancestry. To address this research gap, we examined the genetic basis of fasting glucose, fasting insulin and HbA1c in participants of the diverse Population Architecture using Genomics and Epidemiology (PAGE) Study.

Methods: We conducted a GWAS of fasting glucose (n = 52,267), fasting insulin (n = 48,395) and HbA1c (n = 23,357) in participants without diabetes from the diverse PAGE Study (23% self-reported African American, 46% Hispanic/Latino, 40% European, 4% Asian, 3% Native Hawaiian, 0.8% Native American), performing transethnic and population-specific GWAS meta-analyses, followed by fine-mapping to identify and characterise novel loci and independent secondary signals in known loci.

Results: Four novel associations were identified (p < 5 × 10-9), including three loci associated with fasting insulin, and a novel, low-frequency African American-specific locus associated with fasting glucose. Additionally, seven secondary signals were identified, including novel independent secondary signals for fasting glucose at the known GCK locus and for fasting insulin at the known PPP1R3B locus in transethnic meta-analysis.

Conclusions/interpretation: Our findings provide new insights into the genetic architecture of glycaemic traits and highlight the continued importance of conducting genetic studies in diverse populations.

Data availability: Full summary statistics from each of the population-specific and transethnic results are available at NHGRI-EBI GWAS catalog ( https://www.ebi.ac.uk/gwas/downloads/summary-statistics ).

Keywords: Fine-mapping; Genome-wide association study; Glucose; Glycaemic traits; HbA1c; Insulin; Transethnic population.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Manhattan plots for glycaemic trait association analyses in PAGE, adjusting for BMI. (a) Fasting insulin transethnic meta-analysis results. (b) HbA1c transethnic meta-analysis results. (c) Fasting glucose transethnic meta-analysis results. (d) Fasting glucose AA-specific meta-analysis results. Known loci are shown in grey; novel loci with p value < 1 × 10−6 are shown in purple; novel loci with p value < 5 × 10−9 are shown in pink
Fig. 2
Fig. 2
Forest plots of primary GWAS and replication transethnic and population-specific meta-analysis effect estimates and 95% CIs for the four novel variants identified in the PAGE Study. (a) Fasting glucose variant rs571025315 at LRRC37A5P locus, which was genome-wide significant (p < 5 × 10−9) only in AA-specific meta-analysis. Effective n < 30 for all other populations in the primary analysis, indicated by sample size n = NA in the primary analysis panel. (b) Fasting insulin variant rs9472142 at VEGFA locus. (c) Fasting insulin variant rs35131928 at CASC8/CASC21 locus; EA REGARDS replication data used proxy variant rs10956361 in lieu of rs35131928 (D′ = 1 and r2 = 1 with rs35131928 in EA PAGE data). (d) Fasting insulin variant rs10887773 at PTEN locus. PAGE Study GWAS results for transethnic and population-specific meta-analyses are shown against a white background; transethnic and population-specific meta-analyses of replication results are shown against a grey background. Replication data sources, by population, are as follows: AA, JHS, REGARDS; EA, REGARDS, MESA, MAGIC; HA, MESA, CCHC; and ASN, MESA, CHNS

References

    1. Cowie C, Casagrande S, Geiss L (2018) Prevalence and incidence of type 2 diabetes and prediabetes. In: Cowie C, Casagrande S, Menke A et al. (eds) Diabetes in America: 3rd edition, vol 17–1468. National Institutes of Health, Bethesda, MD
    1. Tancredi M, Rosengren A, Svensson AM et al. (2015) Excess mortality among persons with type 2 diabetes. N Engl J Med 373(18):1720–1732. 10.1056/NEJMoa1504347 - DOI - PubMed
    1. Rowley WR, Bezold C, Arikan Y, Byrne E, Krohe S (2017) Diabetes 2030: insights from yesterday, today, and future trends. Popul Health Manag 20(1):6–12. 10.1089/pop.2015.0181 - DOI - PMC - PubMed
    1. Huang ES, Basu A, O’Grady M, Capretta JC (2009) Projecting the future diabetes population size and related costs for the U.S. Diabetes Care 32(12):2225–2229. 10.2337/dc09-0459 - DOI - PMC - PubMed
    1. Dupuis J, Langenberg C, Prokopenko I et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42(2):105–116. 10.1038/ng.520 - DOI - PMC - PubMed

Publication types

MeSH terms

Grants and funding